Tumor biomarkers play important roles in tumor growth, invasion, and metastasis. Imaging of
specific biomarkers will help to understand different biological activities, thereby achieving …

Head and neck squamous cell carcinomas (HNSCCs) are often aggressive, making
advanced disease very difficult to treat using contemporary modalities, such as surgery …

The incidence of head and neck squamous cell carcinoma (HNSCC) is increasing and
currently they account for 5% of all malignancies worldwide. Inspite of ongoing …

Head and neck (HN) cancer is a heterogeneous malignancy that involves multiple sites and
cellular origins, commonly arising from the oral cavity, oropharynx, hypopharynx, larynx …

Precision treatment requires precision imaging. With the advent of various advanced
techniques in head and neck cancer treatment, imaging has become an integral part of the …

Recent advances made in treatment for head and neck squamous cell carcinoma (HNSCC)
highlight the need for new prediction tools to guide therapeutic strategies. In this study, we …

Functional imaging has become an increasingly important diagnostic tool for head and neck
cancer, and as its availability increases so will its utilization. Positron emission tomography …

Purpose: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common
cancer worldwide, with high mortality and a lack of targeted therapies. To identify and …

Background The role of imaging in the staging, treatment planning, and ongoing
surveillance of patients with head and neck squamous cell carcinoma (HNSCC) continues to …

Molecular targeted therapy in head and neck squamous cell carcinoma (HNSCC) continues
to make strides, and holds much promise. Cetuximab remains the sole US FDA-approved …